Summary A panel of lipid, carbohydrate and protein antibodies were optimized for use in detecting M. leprae antigens in paraffin embedded material. Skin and nerve biopsies from 13 patients across the leprosy spectrum were studied. All antibodies detected antigen in tissues with a BI > 1. Phenolic-glycolipid was not detected in bacteriologically negative tissue but lipoarabinomanan (LAM) and protein antigens were detected. Staining with LAM was strongest and gave least background. The transfer of this immunohistochemical technique to paraffin embedded material will allow examination of tissue with better morphology and from clinics without access to tissue freezing facilities.
The paucity of M. leprae bacilli in tuberculoid leprosy disease spectrum in leprosy poses diagnostic difficulties histologically. One potential solution to this problem is to use antibodies against M. Zeprae antigens in immunohistochemical techniques to detect indi vidual antigens rather than bacilli. M. leprae has protein, lipid and carbohydrate antigens. The lipid and carbohydrate antigens are found in the M. leprae cell wall. Phenolic glycolipid is unique to M. Zeprae, lipoarabinomannan is a soluble polysaccharide and is present in other mycobacteria. M. leprae has numerous protein antigens; the 65 kDa is a ht;at shock protein and 30 kDa is a secreted antigen. Immunohistochemical studies have been done on leprosy infected tissue using anti-BeG monoclonals 1 , 2 and monoclonal antibodies (rnAbs) directed against phenolicglycolipid-l (PGL_ l), 3 -5 lipoarabinomannan (LAM) 6 , 5 and different protein epitopes of M. leprae3,6-1O,14 to detect these antigens. Most of these studies were performed on skin biopsies; only three workers have reported results of staining nerve biopsies for leprosy antigens. 
IMMUNOHISTOCHEMICAL STAINING
Routine staining procedures (Dako) for immunohistochemistry of paraffin-embedded tissue sections were followed. Sections were incubated for 20 min in normal goat serum to block non-specific staining. The antibodies DZ-l (PGL-l) and F26-7 (LAM) (Amsterdam) were diluted in a pre-evaluated dilution of 1 :250 in PBS (phosphate buffered saline) and applied to the sections for 1 h, at room temperature. Pre-treatment in a trypsin-chymotrypsin bath for 15 min, at 37°C was required for sections stained with the antibodies 3A8 (30 kD) and F67-2 (65 kD). These antibodies were used at an optimal dilution of 1:75 and 1:1000 in PBS, respectively, with an overnight incubation at 4°C. The macrophage marker PG-Ml (Dako Cat No M0876) specific for CD68 was diluted 1 in 50 and applied for 1 h at room temperature. The sections were subsequently incubated with biotinylated rabbit anti-mouse immuno globulin (Dako Cat. No. E4 13) diluted 1:200 in PBS + 10% human AB serum for 30 min and finally incubated with streptABComplexIHRP (Dako No. K377) for 30 min. The peroxidase reaction was visualized using 3,3 ' diarninobenzidine tetrahydrochloride (DAB Sigmafast) for 5-10 min at room temperature and the sections were counterstained with haematoxylin. The specificity of the antibody staining was checked by omitting the primary antibody in at least one section from each patient. 
Results
The characteristics of the four mAbs used in this study are listed in Table 1 . At the start of the study, eight other mAbs (Table 2) were also tested on paraffin preserved material. However, no positive antigenic staining was found using dilutions around the optimal dilution for use on frozen material and following the above protocol.
Staining intensity patterns of the four M. leprae mAbs used in this study (directed against PGL-l, LAM, 30 kD and 65 kD) are shown in Table 3 , together with data on bacillary index, CD68 positivity patterns and patient details. For grading purposes numbers of positively Figure 1 . continued stained infiltrating cells were counted semi-quantitatively by two observers. PGL-l and LAM positive staining was found to be lowest at the tuberculoid pole and strongest at the lepromatous pole. Control samples were negative for antibody staining except for some 65 kD positivity in occasional subepidermal macrophages (identified by morphology) in psoriasis skin. In post mortem normal nerve tissue, a weak diffuse staining pattern was found within Schwann cells when staining for LAM.
SKIN
Both the PGL-l and LAM antibodies gave intracellular granular staining in infiltrating macrophages and a clear vesicular staining pattern in foamy macrophages, although the latter pattern is mainly seen with LAM antibody staining (Figures lA and B) . With the PGL-l antibody a weak: diffuse staining was present in granulomata, this was not seen with LAM antibody staining. Occasionally some Langerhans cells stained positively with both the PGL-l and LAM antibodies. With the 30 kD and 65 kD antibodies, staining of infiltrating cells was seen principally on cell membrane and nuclei with cytoplasm staining weakly (for 30 kD see Figure 1 C ). The intensity of the staining with the protein antibodies paralleled the macrophage infiltrate in the lesions. A diffuse granular staining observed within granulomas 
NERVE
The 30 kD antigen could not be demonstrated in leprosy infected nerve tissue using the 3A8 antibody. For the other antigens the staining intensity paralleled the bacterial load and macrophage infiltrate ( Figure 2D ). In PGL-l antibody stained samples PGL-l was detected in infiltrating cells, mainly macrophages, in both granular and vesicular patterns (Figure 2A ). The LAM antibody shows the same pattern, again staining foamy macrophages and with considerably less background staining than the PGL-I antibody ( Figure 2B ). The 65 kD mAb showed staining in infiltrating cells, but principally on the membranes and nuclei of those cells ( Figure 2C ). No identifiable bacteria were stained with the mAbs used in these skin and nerve sections. For both skin and nerve, positive staining was confined to areas where macrophages are found abundantly (Figures lA-D) .
In all infected skin tissue samples positive staining was also occasionally found in cells of the following cell lineages: melanocytes, vascular and sweat gland endothelial cells, hair follicles, and arrector pili muscle fibres. We have observed this epiphenomenon previously.
Discussion
In this study we have identified four mAbs that detect M. Zeprae antigens in paraffin embedded material. Using paraffin embedded material rather than frozen sections has the advantages that the morphology is much better preserved and specimens can be transported from remote areas for paraffin embedding.
The diagnosis of tuberculoid leprosy may be difficult when there are few granulomata, no definite nerve infiltration and no detectable acid fast bacilli. In such cases an antibody which stained antigen positive when Fite-Faraco staining was negative would be useful. In our study the LAM antibody would fulfil some of these criteria, because although both the PGL-I and LAM antibody staining intensity correlated with the acid fast bacilli load the LAM antibody also stained positively in Fite-Faraco negative tissues whilst PGL-l staining was negative at the tuberculoid pole. With the PGL-I antibody (DZ-l) used here, four of the five TTIBT patients with a BI 0 had no detectable PGL-I, whether or not they had been treated. This contrasts with the work of Narayanan et at. 3 and Wang et aZ} who demonstrated the presence of PGL-l antigens in bacteriologically negative tissue. The staining for LAM antigens was strongest and clearest, with less background than with the protein and lipid antibodies. One problem with the LAM antibody was that the normal nerve also stained positively with this antibody. This phenomenon has also been reported by Shetty et at. 4 and there may be cross reactive epitopes for LAM and nerve tissue. However, further work would be needed in a prospective study comprising patients with leprosy and other skin conditions to determine the sensitivity and specificity of this antibody.
In patients 6 and 10, who had both received many months of treatment (Table 3) , staining for all antigens was still positive. This is in accordance with other workers who have found long term persistence of mycobacterial antigens in skin and nerve. 4 , 1l The nerve sections used in this study could only be analysed for PGL-I, LAM and 65 kD staining, since the mAb against 30 kD (3A8) did not produce any positive staining in these sections. For PGL-I and LAM, positive staining in nerve material when compared with staining in the corresponding skin correlated directly with the AFB load. Only PGL-I showed an overall higher intensity staining in nerve material (three out of five cases), supporting the statement that mycobacterial antigen load is usually higher in nerve when compared with skin from the same patient. 4 , 11 Using a panel of antibodies on paraffin embedded material permits future work assessing the amount and location of the different M. Zeprae carbohydrate, lipid and protein antigens in leprosy lesions. Defining M. Zeprae antigens in leprosy, in different disease types and at different sites may extend our understanding of the pathology of leprosy and may thus lead to new diagnostic and therapeutic modalities.
